MRK
Merck & Company, Inc.
103.74
USD
This page is just a preview of the data found in TrendSpider’s full version
Merck & Company, Inc. stock is up 1.33% since 30 days ago. The dividend yield is 3.04% and its next earnings date is Feb 1, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 58% of the previous 49 December’s closed higher than November. In the last 10 Unusual Options Trades, there were 8 CALLs, 2 PUTs. 100% of analysts rate it a buy.
| Date & Time | Expiration Date | Strike Price | Trade Type | Size | Open Interest |
|---|---|---|---|---|---|
| 06 Dec 14:52 | 19 Jan, 2024 | 100.00 | 4670 | ||
| 06 Dec 17:01 | 21 Jun, 2024 | 70.00 | 114 | ||
| 07 Dec 14:45 | 17 Jan, 2025 | 95.00 | 879 | ||
| 07 Dec 15:41 | 19 Jan, 2024 | 100.00 | 4676 | ||
| 07 Dec 15:45 | 17 Jan, 2025 | 105.00 | 5358 | ||
| 07 Dec 16:14 | 16 Jan, 2026 | 80.00 | 10 | ||
| 07 Dec 19:54 | 17 Jan, 2025 | 115.00 | 1522 | ||
| 08 Dec 15:02 | 17 Jan, 2025 | 90.00 | 1264 | ||
| 08 Dec 17:45 | 17 May, 2024 | 90.00 | 15 | ||
| 08 Dec 20:20 | 19 Jan, 2024 | 77.50 | 293 |
Merck & Co. operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services.
